Italy vs Timor-Leste: Pneumococcal conjugate second or third-dose vaccines (PCVc)
Italy
82.0%
in 2025
Timor-Leste
82.0%
in 2025
Italy rank
104th
Timor-Leste rank
104th
Pneumococcal conjugate second or third-dose vaccines (PCVc) over time
- Italy
- Timor-Leste
How they compare
Italy currently reports 82.0% against 82.0% in Timor-Leste, a difference of 0.0%.
The two have swapped places 1 time across 18 shared years of data; in 2008 it was Italy ahead.
Italy ranks 104th and Timor-Leste ranks 104th of 192 countries.
Italy has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Italy | Timor-Leste | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 63.0% | 0.0% | 63.0% | Italy |
| 2010s | 85.5% | 0.0% | 85.5% | Italy |
| 2020s | 89.7% | 36.5% | 53.2% | Italy |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher pneumococcal conjugate second or third-dose vaccines (pcvc), Italy or Timor-Leste?
- Italy, at 82.0% against 82.0% in Timor-Leste as of 2025.
- What is the difference in pneumococcal conjugate second or third-dose vaccines (pcvc) between Italy and Timor-Leste?
- 0.0%, with Italy ahead.
- How many years of comparable data are there for Italy and Timor-Leste?
- 18 years are reported by both, from 2008 to 2025.
- How do Italy and Timor-Leste rank globally for pneumococcal conjugate second or third-dose vaccines (pcvc)?
- Italy ranks 104th and Timor-Leste ranks 104th of 192 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Pneumococcal conjugate second or third-dose vaccines (PCVc) immunization coverage by the locally recommended age (%) (WUENIC). Statizoid refreshes it automatically from the source and publishes the full history for both places.